GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome

عرض إصدارات أخرى (1)

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Reinhardt, K, Kate, A, Bohmer, K, Vyas, P, Dirk, R
التنسيق:	Conference item
منشور في:	2010

مواد مشابهة

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
حسب: Reinhardt, K, وآخرون
منشور في: (2010)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
حسب: Alford, K, وآخرون
منشور في: (2011)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
حسب: Maroz, A, وآخرون
منشور في: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
حسب: Maroz, A, وآخرون
منشور في: (2014)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
حسب: Garnett, C, وآخرون
منشور في: (2019)

Myeloid pre-leukemia and leukemia of Down syndrome
حسب: Cruz Hernandez, D, وآخرون
منشور في: (2020)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
حسب: Hasle, H, وآخرون
منشور في: (2008)

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.
حسب: Hellebostad, M, وآخرون
منشور في: (2005)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
حسب: Zhenzhen Yang, وآخرون
منشور في: (2019-08-01)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
حسب: Vyas, P, وآخرون
منشور في: (2008)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
حسب: Cruz Hernandez, D, وآخرون
منشور في: (2020)

Acute leukemias in children with Down syndrome.
حسب: Zwaan, C, وآخرون
منشور في: (2010)

Acute leukemias in children with Down syndrome.
حسب: Zwaan, M, وآخرون
منشور في: (2008)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
حسب: Norton, A, وآخرون
منشور في: (2007)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
حسب: Labuhn, M, وآخرون
منشور في: (2019)

Natural history of GATA-1 mutations in Down syndrome.
حسب: Ahmed, M, وآخرون
منشور في: (2003)

Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
حسب: Brahim Arkoun, وآخرون
منشور في: (2023-04-01)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
حسب: Tunstall-Pedoe, O, وآخرون
منشور في: (2008)

Natural history of GATA1 mutations in Down syndrome.
حسب: Ahmed, M, وآخرون
منشور في: (2004)

Down syndrome preleukemia and leukemia.
حسب: Maloney, K, وآخرون
منشور في: (2014)

GATA2 DEFICIENCY SYNDROME: MDS / ACUTE MYELOID LEUKEMIA IN AN ADOLESCENT PATIENT
حسب: Sebnem Yilmaz, وآخرون
منشور في: (2023-12-01)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
حسب: Heald, B, وآخرون
منشور في: (2007)

A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
حسب: Ana C Xavier, وآخرون
منشور في: (2011-01-01)

DNMT3A mutations are rare in childhood acute myeloid leukemia
حسب: Felicitas Thol, وآخرون
منشور في: (2011-08-01)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
حسب: Halsey, C, وآخرون
منشور في: (2006)

Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of <i>GATA1</i> and <i>STAG2</i> Mutations in Induced Pluripotent Stem Cells with Trisomy 21
حسب: Sonali P. Barwe, وآخرون
منشور في: (2022-02-01)

GATA1 mutational analysis in chronic myeloid leukaemia.
حسب: Halsey, C, وآخرون
منشور في: (2007)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
حسب: Roberts, I, وآخرون
منشور في: (2013)

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study
حسب: Marius Flasinski, وآخرون
منشور في: (2018-07-01)

Molecular insights into Down syndrome-associated leukemia.
حسب: Vyas, P, وآخرون
منشور في: (2007)

GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
حسب: Li Yang, وآخرون
منشور في: (2017-01-01)

BCOR and BCORL1 mutations in pediatric acute myeloid leukemia
حسب: Jasmijn D.E. de Rooij, وآخرون
منشور في: (2015-05-01)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
حسب: Maximiliano Cloobs Venezia, وآخرون
منشور في: (2022-11-01)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
حسب: Li Yang, وآخرون
منشور في: (2017-01-01)

GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells
حسب: Koichi R. Katsumura, وآخرون
منشور في: (2016-08-01)

Myelodysplastic syndrome due to somatic GATA1 mutation.
حسب: Freson, K, وآخرون
منشور في: (2004)

Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with <i>GATA1</i> mutation
حسب: Yoko Nishinaka-Arai, وآخرون
منشور في: (2020-04-01)

Acute Kidney Injury in Myeloid Leukemia of Down Syndrome: Risk Factors and Outcomes
حسب: Chompoonut Limratchapong, وآخرون
منشور في: (2023-03-01)

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features
حسب: Marlise R. Luskin, وآخرون
منشور في: (2015-10-01)

The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
حسب: Bernhard Moser, وآخرون
منشور في: (2021-08-01)